| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 274.94B | 266.44B | 257.06B | 225.18B | 216.82B | 209.23B |
| Gross Profit | 47.05B | 44.75B | 40.83B | 35.93B | 35.11B | 33.56B |
| EBITDA | 20.48B | 19.68B | 16.99B | 14.62B | 16.20B | 16.41B |
| Net Income | 10.37B | 8.96B | 7.28B | 7.31B | 6.91B | 5.49B |
Balance Sheet | ||||||
| Total Assets | 285.66B | 266.44B | 260.10B | 226.91B | 221.21B | 212.06B |
| Cash, Cash Equivalents and Short-Term Investments | 22.46B | 28.47B | 23.38B | 22.75B | 26.60B | 23.05B |
| Total Debt | 60.30B | 51.81B | 51.21B | 53.09B | 53.00B | 54.96B |
| Total Liabilities | 167.46B | 153.37B | 151.37B | 126.47B | 126.94B | 123.22B |
| Stockholders Equity | 117.39B | 112.03B | 107.01B | 98.75B | 92.47B | 87.94B |
Cash Flow | ||||||
| Free Cash Flow | -3.67B | 10.25B | 8.49B | 2.15B | 11.51B | 12.36B |
| Operating Cash Flow | 6.04B | 20.50B | 14.06B | 6.40B | 16.00B | 18.12B |
| Investing Cash Flow | -11.75B | -12.54B | -8.22B | -7.93B | -7.22B | -9.13B |
| Financing Cash Flow | 4.92B | -3.38B | -5.88B | -3.34B | -5.20B | -5.97B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥181.07B | 12.04 | 8.27% | 2.68% | -2.45% | 7.31% | |
77 Outperform | ¥62.62B | 11.67 | 16.91% | 2.28% | 12.37% | 26.48% | |
73 Outperform | ¥245.13B | 9.23 | ― | 3.90% | 2.65% | 7.16% | |
65 Neutral | ¥258.99B | 14.72 | 8.35% | 2.73% | 3.35% | 810.44% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥165.97B | 8.92 | 9.14% | 2.84% | 0.26% | 14.29% | |
53 Neutral | ¥329.15B | -15.81 | -20.43% | 3.72% | -8.20% | ― |